Sheel Biotech Limited (NSE:SHEEL)

Sheel Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	21.83	4.64	6.03	2.11	3.11
Short-Term Investments	69.95	16.06	12.27	12.59	-
Cash & Short-Term Investments	91.78	20.7	18.3	14.7	3.11
Cash Growth	343.43%	13.12%	24.46%	372.66%	-93.23%
Accounts Receivable	812.22	550.79	577.01	560.46	647.07
Other Receivables	0.25	0.26	-	-	-
Receivables	814.61	555.35	577.01	560.46	647.07
Inventory	295.65	393.85	327.74	193	118.28
Prepaid Expenses	1.67	0.78	0.29	0.46	0.75
Other Current Assets	74.56	20.86	30.66	59.36	30.75
Total Current Assets	1,278	991.54	954.01	827.97	799.96
Property, Plant & Equipment	129.2	74.75	72.21	79.11	77.64
Long-Term Investments	39.44	43.08	8.02	8.02	8.02
Other Intangible Assets	0.12	0.14	0.16	0.19	0.28
Long-Term Deferred Tax Assets	1.05	0.67	1.07	-	-
Other Long-Term Assets	9.76	3.46	24	23.66	46.73
Total Assets	1,458	1,114	1,059	938.94	932.63

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	30.6	41.41	45.86	82.03	83.4
Accrued Expenses	10.55	8.04	9.5	8.82	10.18
Short-Term Debt	74.2	123.43	130.12	78.59	91.53
Current Portion of Long-Term Debt	3.15	1.95	2.59	18.7	4.69
Current Income Taxes Payable	1.69	1.91	19.9	13.24	-
Other Current Liabilities	49.54	44.04	18.1	3.78	0
Total Current Liabilities	169.73	220.79	226.07	205.16	189.81
Long-Term Debt	12.44	48.23	102.68	94.41	139.61
Pension & Post-Retirement Benefits	5.76	5.9	3.81	2.91	-
Long-Term Deferred Tax Liabilities	-	-	-	1.05	0.36
Other Long-Term Liabilities	-	0	-	-	-
Total Liabilities	187.93	274.91	332.56	303.53	329.77

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	203.53	149.53	41.44	41.44	41.44
Additional Paid-In Capital	275.36	15.74	4	4	-
Retained Earnings	787.03	669.47	681.47	589.98	561.42
Comprehensive Income & Other	4	4	-	-	-
Shareholders' Equity	1,270	838.73	726.9	635.42	602.86
Total Liabilities & Equity	1,458	1,114	1,059	938.94	932.63

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	89.79	173.61	235.4	191.71	235.83
Net Cash (Debt)	1.99	-152.91	-217.1	-177.01	-232.72
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	0.11	-10.35	-14.97	-12.20	-16.05
Filing Date Shares Outstanding	20.35	20.35	14.5	4.14	4.14
Total Common Shares Outstanding	20.35	14.95	14.5	4.14	4.14
Working Capital	1,109	770.76	727.93	622.81	610.15
Book Value Per Share	62.40	56.09	50.12	153.34	145.49
Tangible Book Value	1,270	838.59	726.74	635.23	602.58
Tangible Book Value Per Share	62.39	56.08	50.11	153.30	145.42
Land	77.18	58.87	20.76	20.76	20.76
Buildings	5.89	5.89	39.4	39.4	37.98
Machinery	155.42	146.55	140.06	137.12	116.18
Construction In Progress	34.54	-	-	-	1.41

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 1, 2026

Data Sources Report a data error